Clinical Evaluation of Two Different Attachment System
ADLCvsLOC
Evaluation of Patient Reported Outcome Measures and Clinical Performance of Implant Supported Overdentures With Two Different Attachment Systems: A Randomized Cross Over Clinical Study
1 other identifier
interventional
26
1 country
1
Brief Summary
Edentulous patients commonly experience a deterioration in the quality of life; both in terms of oral and general health. Studies demonstrated that conventional dentures do not adequately restore masticatory function nor quality of life. In contrast, implant-supported overdentures are considered the standard of care for edentulous patients as they offer a more stable prosthesis that ultimately results in improved oral function and patient satisfaction. Precision attachments such as studs, magnets, telescopic crowns or a bars are commonly used for implant supported overdentures. Implant overdentures supported by stud attachments gained popularity for the rehabilitation of edentulous patients as they are self-aligning, offer dual retention and compensate for divergence between implants up to angles of 40 degrees. However, it has been documented that the stud attachment system (Locators) requires a high frequency of maintenance, particularly with regard to the replacement of the matrix. In order to overcome some of these limitations of existing attachment systems, a newer system was developed consisting of a matrix made of polyetheretherketone (PEEK) instead of a polymeric material. This system has an amorphous diamond like carbon-based abutment coating (ADLC) and it was claimed to be more resistant to wear. Clinically and in vitro, no comparative studies have been performed addressing wear and retention of the traditional stud attachment and the newer ADLC attachment. Thus, the aim of the present study is to clinically and in vitro evaluate the ADLC and study attachment system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 26, 2020
CompletedFirst Posted
Study publicly available on registry
September 10, 2020
CompletedStudy Start
First participant enrolled
November 2, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2028
ExpectedJune 24, 2022
June 1, 2022
2.1 years
August 26, 2020
June 23, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Patient reported outcome measure
Mean VAS scores (visual analogue scale (0-100)) related to patient overall satisfaction for the ADLC and the LOC (Locator) attachment system provided by the patients
After a functional period of 6 months
Secondary Outcomes (7)
Patient-Reported Outcome Measures (PROMs): VAS
6 months, 1, 3, 5 years after the evaluation period of the second attachment systems
Patient-Reported Outcome Measures (PROMs): OHIP-14
6 months, 1, 3, 5 years after the evaluation period of the second attachment systems
Patient-Reported Outcome Measures (PROMs): Costs
6 months, 1, 3, 5 years after the evaluation period of the second attachment systems
Technical outcomes:
6 months after the first and the second evaluation period, respectively
Clinical outcomes: PCR
after a functional period of 6 months for each attachment system; and1, 3 and 5 years after the evaluation period of the second attachment systems
- +2 more secondary outcomes
Study Arms (2)
ADLC attachment in first phase
EXPERIMENTALEach patient will receive 2 implants in the canine region. Three months later, each patient will be randomized and half of the patients will receive first the ADLC (test) device (first phase). In the second phase of the crossover trial (6 months after the start of the first phase), the attachments will be replaced. Patients previously allocated to the ADLC group will receive the LOC attachments.
LOC attachment in first phase
ACTIVE COMPARATOREach patient will receive 2 implants in the canine region. Three months later, each patient will be randomized and half of the patients will receive first the LOC (control) device (first phase). In the second phase of the crossover trial (6 months after the start of the first phase), the attachments will be replaced. Patients previously allocated to the LOC group will receive the ADLC attachments.
Interventions
Each patient will receive 2 implants in the canine region using a guided-surgery protocol and a pre-prepared surgical stent. A healing abutment of an adequate size will be placed on the implant for transmucosal healing. The flaps will be subsequently sutured around the healing abutments. Patients' existing prostheses will be adjusted. Suture removal will be performed one week post implant placement. Three months later, implant level impressions will be made using the open tray technique. Each patient will be then be randomized using eCRF (electronic Case Report Form) to either ADLC group or LOC group. A final cast of the patients will be obtained and the attachments will be installed using an in-direct technique by a calibrated prosthodontists.
Eligibility Criteria
You may qualify if:
- Fully edentulous patients encountering problems (functional, aesthetics) with existing dentures in the upper and lower jaw or patients seeking for implant-supported prostheses
- Adequate bone in the anterior mandible for the placement of implants (Regular diameter implant with a minimal length of 10mm) in the canine region
- Written informed consent
- Ability to understand the procedure and to answer a questionnaire.
You may not qualify if:
- Impaired cognitive function and/or manual dexterity
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant
- Unable to attend follow-up examinations
- Known or suspected non-compliance, drug or alcohol abuse
- Presence of any uncontrolled systematic disease that could compromise implant surgery and implant long-term performance
- History of radiotherapy in the head and neck region
- Heavy smoker (\>10 cig. /day
- Any potential allergies or hypersensitivity to chemical ingredients of material used
- Bruxism
- Presence of bone metabolic disorders (e.g. osteoporosis)
- Pregnant or lactating women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
M.A.Rangoonwala College of Dental Sciences & Research Center
Pune, 411001, India
Study Officials
- PRINCIPAL INVESTIGATOR
Mohit Kheur, Prof.
M.A.Rangoonwala College of Dental Sciences & Research Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 26, 2020
First Posted
September 10, 2020
Study Start
November 2, 2020
Primary Completion
December 1, 2022
Study Completion (Estimated)
January 1, 2028
Last Updated
June 24, 2022
Record last verified: 2022-06